REFERENCES
1. Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is
polypharmacy? A systematic review of definitions. BMC Geriatr .
Oct 10 2017;17(1):230. doi:10.1186/s12877-017-0621-2
2. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B.
Epidemiology of multimorbidity and implications for health care,
research, and medical education: a cross-sectional study. Lancet
(London, England) . 2012/07/07 2012;380(9836):37-43.
doi:10.1016/s0140-6736(12)60240-2
3. Young EH, Pan S, Yap AG, Reveles KR, Bhakta K, Suppiah V.
Polypharmacy prevalence in older adults seen in United States physician
offices from 2009 to 2016. PloS one . 2021/08/03
2021;16(8):e0255642. doi:10.1371/journal.pone.0255642
4. Morgan T, Williamson M, Pirotta M, Stewart K, Myers S, Barnes J. A
national census of medicines use: a 24-hour snapshot of Australians aged
50 years and older. The Medical journal of Australia . 2012/01/16
2012;196(1):50-3. doi:10.5694/mja11.10698
5. Chang TI, Park H, Kim DW, et al. Polypharmacy, hospitalization, and
mortality risk: a nationwide cohort study. Scientific Reports .
2020/11/03 2020;10(1):18964. doi:10.1038/s41598-020-75888-8
6. Jokanovic N, Tan EC, Dooley MJ, Kirkpatrick CM, Bell JS. Prevalence
and factors associated with polypharmacy in long-term care facilities: a
systematic review. J Am Med Dir Assoc . Jun 1 2015;16(6):535
e1-12. doi:10.1016/j.jamda.2015.03.003
7. Muhlack DC, Hoppe LK, Weberpals J, Brenner H, Schöttker B. The
Association of Potentially Inappropriate Medication at Older Age With
Cardiovascular Events and Overall Mortality: A Systematic Review and
Meta-Analysis of Cohort Studies. Journal of the American Medical
Directors Association . 2017/03/01 2017;18(3):211-220.
doi:10.1016/j.jamda.2016.11.025
8. Wastesson JW, Morin L, Tan ECK, Johnell K. An update on the clinical
consequences of polypharmacy in older adults: a narrative review.Expert opinion on drug safety . 2018/12/02 2018;17(12):1185-1196.
doi:10.1080/14740338.2018.1546841
9. Gutiérrez-Valencia M, Izquierdo M, Cesari M, Casas-Herrero Á,
Inzitari M, Martínez-Velilla N. The relationship between frailty and
polypharmacy in older people: A systematic review: Frailty and
polypharmacy: A systematic review. British Journal of Clinical
Pharmacology . 2018/07 2018;84(7):1432-1444. doi:10.1111/bcp.13590
10. Donaldson LJ, Kelley ET, Dhingra-Kumar N, Kieny M-P, Sheikh A.
Medication Without Harm: WHO’s Third Global Patient Safety Challenge.Lancet (London, England) . 2017/04/29 2017;389(10080):1680-1681.
doi:10.1016/s0140-6736(17)31047-4
11. Achterhof AB, Rozsnyai Z, Reeve E, et al. Potentially inappropriate
medication and attitudes of older adults towards deprescribing.PloS one . 2020;15(10):e0240463. doi:10.1371/journal.pone.0240463
12. Davies EA, O’Mahony MS. Adverse drug reactions in special
populations - the elderly. British Journal of Clinical
Pharmacology . 2015/10 2015;80(4):796-807. doi:10.1111/bcp.12596
13. Tommelein E, Mehuys E, Petrovic M, Somers A, Colin P, Boussery K.
Potentially inappropriate prescribing in community-dwelling older people
across Europe: a systematic literature review. European journal of
clinical pharmacology . 2015/12 2015;71(12):1415-1427.
doi:10.1007/s00228-015-1954-4
14. Kalisch LM, Caughey GE, Barratt JD, et al. Prevalence of preventable
medication-related hospitalizations in Australia: an opportunity to
reduce harm. International Journal for Quality in Health Care .
2012/06/01 2012;24(3):239-249. doi:10.1093/intqhc/mzs015
15. Dills H, Shah K, Messinger-Rapport B, Bradford K, Syed Q.
Deprescribing Medications for Chronic Diseases Management in Primary
Care Settings: A Systematic Review of Randomized Controlled Trials.Journal of the American Medical Directors Association . 2018/11
2018;19(11):923-935. doi:10.1016/j.jamda.2018.06.021
16. Thio SL, Nam J, van Driel ML, Dirven T, Blom JW. Effects of
discontinuation of chronic medication in primary care: a systematic
review of deprescribing trials. British Journal of General
Practice . 2018/10 2018;68(675):e663-e672. doi:10.3399/bjgp18X699041
17. Kua C-H, Mak VSL, Huey Lee SW. Health Outcomes of Deprescribing
Interventions Among Older Residents in Nursing Homes: A Systematic
Review and Meta-analysis. Journal of the American Medical
Directors Association . 2019/03 2019;20(3):362-372.
doi:10.1016/j.jamda.2018.10.026
18. Almutairi H, Stafford A, Etherton-Beer C, Flicker L. Optimisation of
medications used in residential aged care facilities: a systematic
review and meta-analysis of randomised controlled trials. BMC
geriatrics . 2020/07/08 2020;20(1):236. doi:10.1186/s12877-020-01634-4
19. Thillainadesan J, Gnjidic D, Green S, Hilmer SN. Impact of
Deprescribing Interventions in Older Hospitalised Patients on
Prescribing and Clinical Outcomes: A Systematic Review of Randomised
Trials. Drugs & Aging . 2018/04 2018;35(4):303-319.
doi:10.1007/s40266-018-0536-4
20. Cobretti M, Page II R, Linnebur S, et al. Medication regimen
complexity in ambulatory older adults with heart failure. Clinical
Interventions in Aging . 2017;12:679-686. doi:10.2147/cia.S130832
21. Elliott RA, Woodward MC. Medication-related problems in patients
referred to aged care and memory clinics at a tertiary care hospital.Australasian journal on ageing . 2011/09 2011;30(3):124-129.
doi:10.1111/j.1741-6612.2010.00458.x
22. Nightingale G, Hajjar E, Swartz K, Andrel-Sendecki J, Chapman A.
Evaluation of a Pharmacist-Led Medication Assessment Used to Identify
Prevalence of and Associations With Polypharmacy and Potentially
Inappropriate Medication Use Among Ambulatory Senior Adults With Cancer.Journal of clinical oncology : official journal of the American
Society of Clinical Oncology . 2015/05/01 2015;33(13):1453-1459.
doi:10.1200/jco.2014.58.7550
23. Sterne J, Savović J, Page M, et al. RoB 2: A revised tool for
assessing risk of bias in randomised trials. BMJ . 08/28
2019;366:l4898. doi:10.1136/bmj.l4898
24. Sterne JA, Hernán MA, Reeves BC, et al. ROBINS-I: a tool for
assessing risk of bias in non-randomised studies of interventions.BMJ (Clinical research ed) . 2016/10/12 2016;355:i4919.
doi:10.1136/bmj.i4919
25. Dharmarajan TS, Choi H, Hossain N, et al. Deprescribing as a
Clinical Improvement Focus. Journal of the American Medical
Directors Association . 2020/03 2020;21(3):355-360.
doi:10.1016/j.jamda.2019.08.031
26. Lampela P, Hartikainen S, Lavikainen P, Sulkava R, Huupponen R.
Effects of Medication Assessment as Part of a Comprehensive Geriatric
Assessment on Drug Use over a 1-Year Period: A Population-Based
Intervention Study. Drugs & Aging . 2010/06/01
2010;27(6):507-521. doi:10.2165/11536650-000000000-00000
27. Frankfort SV, Tulner LR, van Campen JP, Koks CH, Beijnen JH.
Evaluation of pharmacotherapy in geriatric patients after performing
complete geriatric assessment at a diagnostic day clinic. Clin
Drug Investig . 2006;26(3):169-74. doi:10.2165/00044011-200626030-00007
28. Wei Y-J, Hsieh C-F, Huang Y-T, Huang M-S, Fang T-J. The influence of
integrated geriatric outpatient clinics on the health care utilization
of older people. BMC geriatrics . 2020/10/02 2020;20(1):379.
doi:10.1186/s12877-020-01782-7
29. Unutmaz G, Soysal P, Tuven B, Isik AT. Costs of medication in older
patients: before and after comprehensive geriatric assessment.Clinical Interventions in Aging . 2018;13:607-613.
doi:10.2147/cia.S159966
30. Ammerman C, Simpkins B, Warman N, Downs T. Potentially Inappropriate
Medications in Older Adults: Deprescribing with a Clinical Pharmacist.Journal of the American Geriatrics Society . 2019/01
2019;67(1):115-118. doi:10.1111/jgs.15623
31. Lim WS, Low HN, Chan SP, Chen HN, Ding YY, Tan TL. Impact of a
pharmacist consult clinic on a hospital-based geriatric outpatient
clinic in Singapore. Ann Acad Med Singap . 2004/03//
2004;33(2):220-227.
32. Romskaug R, Skovlund E, Straand J, et al. Effect of Clinical
Geriatric Assessments and Collaborative Medication Reviews by
Geriatrician and Family Physician for Improving Health-Related Quality
of Life in Home-Dwelling Older Patients Receiving Polypharmacy: A
Cluster Randomized Clinical Trial. JAMA Internal Medicine .
2020/02/01 2020;180(2):181-189. doi:10.1001/jamainternmed.2019.5096
33. Choukroun C, Leguelinel-Blache G, Roux-Marson C, et al. Impact of a
pharmacist and geriatrician medication review on drug-related problems
in older outpatients with cancer. Journal of geriatric oncology .
2020/08/13 2020;12(1):57-63. doi:10.1016/j.jgo.2020.07.010
34. Whitman A, DeGregory K, Morris A, Mohile S, Ramsdale E.
Pharmacist-led medication assessment and deprescribing intervention for
older adults with cancer and polypharmacy: a pilot study.Supportive care in cancer : official journal of the Multinational
Association of Supportive Care in Cancer . 2018/12
2018;26(12):4105-4113. doi:10.1007/s00520-018-4281-3
35. McIntyre C, McQuillan R, Bell C, Battistella M. Targeted
Deprescribing in an Outpatient Hemodialysis Unit: A Quality Improvement
Study to Decrease Polypharmacy. American journal of kidney
diseases : the official journal of the National Kidney Foundation .
2017/11 2017;70(5):611-618. doi:10.1053/j.ajkd.2017.02.374
36. George JS, Joseph R, Thomas ETA, John GP, Siby A, Nair MM. Active
deprescribing program in chronic kidney disease patients undergoing
haemodialysis. Nephrology (Carlton, Vic) . 2021/11
2021;26(11):890-897. doi:10.1111/nep.13936
37. Cross AJ, George J, Woodward MC, Le VJ, Elliott RA. Deprescribing
potentially inappropriate medications in memory clinic patients
(DePIMM): A feasibility study. Research in social &
administrative pharmacy : RSAP . 2020/10 2020;16(10):1392-1397.
doi:10.1016/j.sapharm.2020.01.010
38. Yates L, Valente M, Wadsworth C. Evaluation of Pharmacist Medication
Review Service in an Outpatient Heart Failure Clinic. Journal of
pharmacy practice . 2020/12 2020;33(6):820-826.
doi:10.1177/0897190019842696
39. Boersma MN, Huibers CJA, Drenth‐van Maanen AC, Emmelot‐Vonk MH,
Wilting I, Knol W. The effect of providing prescribing recommendations
on appropriate prescribing: A cluster‐randomized controlled trial in
older adults in a preoperative setting. British Journal of
Clinical Pharmacology . 2019/09 2019;85(9):1974-1983.
doi:10.1111/bcp.13987
40. Bennett F, Shah N, Offord R, Ferner R, Sofat R. Establishing a
service to tackle problematic polypharmacy. Future Healthcare
Journal . 2020/10 2020;7(3):208-211. doi:10.7861/fhj.2019-0048
41. Mudge A, Radnedge K, Kasper K, et al. Effects of a pilot
multidisciplinary clinic for frequent attending elderly patients on
deprescribing. Australian health review : a publication of the
Australian Hospital Association . 2016/02 2016;40(1):86-91.
doi:10.1071/ah14219
42. Aharaz A, Rasmussen JH, McNulty HBØ, et al. A Collaborative
Deprescribing Intervention in a Subacute Medical Outpatient Clinic: A
Pilot Randomized Controlled Trial. Metabolites . 2021/03/30
2021;11(4):204. doi:10.3390/metabo11040204
43. Rieg S, Wehling M. FORTA(Fit-fOR-The-Aged)-based medication
optimization: retrospective analysis of experiences from an
unconventional outpatient service. European Geriatric Medicine .
2020/12 2020;11(6):1035-1041. doi:10.1007/s41999-020-00378-z
44. AGS. American Geriatrics Society 2019 Updated AGS Beers Criteria®
for Potentially Inappropriate Medication Use in Older Adults.Journal of the American Geriatrics Society . 2019/04
2019;67(4):674-694. doi:10.1111/jgs.15767
45. Gallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D. STOPP
(Screening Tool of Older Person’s Prescriptions) and START (Screening
Tool to Alert doctors to Right Treatment). Consensus validation.International journal of clinical pharmacology and therapeutics .
2008/02 2008;46(2):72-83. doi:10.5414/cpp46072
46. Hanlon JT, Schmader KE, Samsa GP, et al. A method for assessing drug
therapy appropriateness. J Clin Epidemiol . Oct
1992;45(10):1045-51. doi:10.1016/0895-4356(92)90144-c
47. Crisp GD, Burkhart JI, Esserman DA, Weinberger M, Roth MT.
Development and Testing of a Tool for Assessing and Resolving
Medication-Related Problems in Older Adults in an Ambulatory Care
Setting: The Individualized Medication Assessment and Planning (iMAP)
Tool. The American journal of geriatric pharmacotherapy . 2011/12
2011;9(6):451-460. doi:10.1016/j.amjopharm.2011.10.003
48. Wehling M, Burkhardt H, Kuhn-Thiel A, et al. VALFORTA: a randomised
trial to validate the FORTA (Fit fOR The Aged) classification. Age
and Ageing . 2016/03 2016;45(2):262-267. doi:10.1093/ageing/afv200
49. Whitman AM, DeGregory KA, Morris AL, Ramsdale EE. A Comprehensive
Look at Polypharmacy and Medication Screening Tools for the Older Cancer
Patient. The Oncologist . 2016/06 2016;21(6):723-730.
doi:10.1634/theoncologist.2015-0492
50. Chiu Y-W, Teitelbaum I, Misra M, de Leon EM, Adzize T, Mehrotra R.
Pill Burden, Adherence, Hyperphosphatemia, and Quality of Life in
Maintenance Dialysis Patients. Clinical journal of the American
Society of Nephrology : CJASN . 2009/06 2009;4(6):1089-1096.
doi:10.2215/cjn.00290109
51. Unlu O, Levitan EB, Reshetnyak E, et al. Polypharmacy in Older
Adults Hospitalized for Heart Failure. Circulation Heart failure .
2020/11 2020;13(11):e006977. doi:10.1161/circheartfailure.120.006977
52. Mohamed MR, Ramsdale E, Loh KP, et al. Associations of Polypharmacy
and Inappropriate Medications with Adverse Outcomes in Older Adults with
Cancer: A Systematic Review and Meta-Analysis. Oncologist . Jan
2020;25(1):e94-e108. doi:10.1634/theoncologist.2019-0406
53. Nightingale G, Hajjar E, Pizzi LT, et al. Implementing a
pharmacist-led, individualized medication assessment and planning (iMAP)
intervention to reduce medication related problems among older adults
with cancer. Journal of Geriatric Oncology . 2017/07
2017;8(4):296-302. doi:10.1016/j.jgo.2017.04.005
54. Budnitz DS, Lovegrove MC, Shehab N, Richards CL. Emergency
Hospitalizations for Adverse Drug Events in Older Americans. New
England Journal of Medicine . 2011/11/24 2011;365(21):2002-2012.
doi:10.1056/NEJMsa1103053
55. Duraisingham S, Jubraj B, Marvin V, Kuo S, Bovill I, Poots A.
Stopping inappropriate medicines in the outpatient setting.Geriatric Medicine . 04/01 2015;April 2015:35.
56. Marvin V, Ward E, Poots AJ, Heard K, Rajagopalan A, Jubraj B.
Deprescribing medicines in the acute setting to reduce the risk of
falls. European journal of hospital pharmacy : science and
practice . 2017/01 2017;24(1):10-15. doi:10.1136/ejhpharm-2016-001003
57. Nkansah N, Mostovetsky O, Yu C, et al. Effect of outpatient
pharmacists’ non‐dispensing roles on patient outcomes and prescribing
patterns. The Cochrane Database of Systematic Reviews . 2010/07/07
2010;2010(7):CD000336. doi:10.1002/14651858.CD000336.pub2
58. Gatwood J, Gatwood K, Gabre E, Alexander M. Impact of clinical
pharmacists in outpatient oncology practices: A review. American
Journal of Health-System Pharmacy . 2017/10/01 2017;74(19):1549-1557.
doi:10.2146/ajhp160475
59. Huiskes VJB, van den Ende CHM, Kruijtbosch M, et al. Effectiveness
of medication review on the number of drug-related problems in patients
visiting the outpatient cardiology clinic: A randomized controlled
trial. British journal of clinical pharmacology . 2020/01
2020;86(1):50-61. doi:10.1111/bcp.14125
60. Chan D-C, Chen J-H, Wen C-J, Chiu L-S, Wu S-C. Effectiveness of the
medication safety review clinics for older adults prescribed multiple
medications. Journal of the Formosan Medical Association . 2014/02
2014;113(2):106-113. doi:10.1016/j.jfma.2012.04.013
61. Anderson K, Stowasser D, Freeman C, Scott I. Prescriber barriers and
enablers to minimising potentially inappropriate medications in adults:
a systematic review and thematic synthesis. BMJ Open . 2014/12/08
2014;4(12):e006544. doi:10.1136/bmjopen-2014-006544
62. Vrijkorte E, de Vries J, Schaafsma R, Wymenga M, Oude Munnink T.
Optimising pharmacotherapy in older cancer patients with polypharmacy.European Journal of Cancer Care . 2020/01 2020;29(1):e13185.
doi:10.1111/ecc.13185
63. Martin AW, Heberle AP, Knight JM. Interventions associated with
implementation of a pharmacist-led neurology pharmacotherapy clinic in
an ambulatory care setting. Journal of the American College of
Clinical Pharmacy . 2019/04 2019;2(2):116-122. doi:10.1002/jac5.1039
64. Seden K, Bradley M, Miller ARO, Beadsworth MBJ, Khoo SH. The
clinical utility of HIV outpatient pharmacist prescreening to reduce
medication error and assess adherence. International Journal of
STD & AIDS . 2013/03 2013;24(3):237-241. doi:10.1177/0956462412472428
65. Marin H, Mayo P, Thai V, et al. The impact of palliative care
consults on deprescribing in palliative cancer patients.Supportive care in cancer : official journal of the Multinational
Association of Supportive Care in Cancer . 2020/09 2019;28(9):4107-4113.
doi:10.1007/s00520-019-05234-w
66. Hui RL, Chang CC, Niu F, et al. Evaluation of a Pharmacist-Managed
Antidiabetic Deprescribing Program in an Integrated Health Care System.J Manag Care Spec Pharm . Aug 2019;25(8):927-934.
doi:10.18553/jmcp.2019.25.8.927
67. Gillespie U, Alassaad A, Henrohn D, et al. A Comprehensive
Pharmacist Intervention to Reduce Morbidity in Patients 80 Years or
Older: A Randomized Controlled Trial. Archives of Internal
Medicine . 2009/05/11 2009;169(9):894-900.
doi:10.1001/archinternmed.2009.71
68. Vink J, Morton D, Ferreri S. Pharmacist Identification of
Medication-Related Problems in the Home Care Setting. The
Consultant Pharmacist . 2011/07/01 2011;26(7):477-484.
doi:10.4140/TCP.n.2011.477
69. Chen TF. Pharmacist-Led Home Medicines Review and Residential
Medication Management Review: The Australian Model. Drugs &
aging . 2016/03 2016;33(3):199-204. doi:10.1007/s40266-016-0357-2
70. Abrahami D, McDonald EG, Schnitzer ME, Barkun AN, Suissa S, Azoulay
L. Proton pump inhibitors and risk of gastric cancer: population-based
cohort study. Gut . 2022/01 2022;71(1):16-24.
doi:10.1136/gutjnl-2021-325097
71. Houlind MB, Andersen AL, Treldal C, et al. A Collaborative
Medication Review Including Deprescribing for Older Patients in an
Emergency Department: A Longitudinal Feasibility Study. Journal of
Clinical Medicine . 2020/01/27 2020;9(2):348. doi:10.3390/jcm9020348
72. Johansson T, Abuzahra ME, Keller S, et al. Impact of strategies to
reduce polypharmacy on clinically relevant endpoints: a systematic
review and meta-analysis: Impact of strategies to reduce polypharmacy.British Journal of Clinical Pharmacology . 2016/08
2016;82(2):532-548. doi:10.1111/bcp.12959
73. Ibrahim K, Cox NJ, Stevenson JM, Lim S, Fraser SDS, Roberts HC. A
systematic review of the evidence for deprescribing interventions among
older people living with frailty. BMC Geriatrics . 2021/04/17
2021;21(1):258. doi:10.1186/s12877-021-02208-8